An official website of the United States Government -

Spending

In fiscal year (FY) 2023, total Medicaid spending was $900.3 billion. Of this amount, $619.9 billion was federal spending and $280.4 billion was state spending. This represents 18 percent of U.S. health care spending (2022) and 10.3 percent of federal outlays (FY 2023). Medicaid pays for approximately 42 percent of all long-term services and supports in the U.S., and approximately 24 percent of mental health and substance use disorder services.

Go to our MACStats data book for the most recent detailed data on spending including trends and information broken out by state and eligibility group.

Learn More about These Topics

Featured Publications

Spending and Utilization for Medicaid Home- and Community-Based Services

July 24, 2025

Medicaid home- and community-based services (HCBS) are designed to allow people with long-term services and supports (LTSS) needs to live in their homes or a home-like setting in the community. In this brief, we focus on HCBS users and expenditures. This analysis found that, nationally, the number of Medicaid beneficiaries using HCBS increased while the number of institutional LTSS […]

State Options to Address Medicaid Spending Growth

April 10, 2025

The federal government and the states share responsibility for financing Medicaid. States receive federal matching funds for allowable state expenditures on an open-ended basis. As state spending increases or decreases, so does federal spending. When states experience circumstances such as unexpected variation in economic conditions on the health system and changes to federal policy, Medicaid’s […]

High-Cost Drugs and the Medicaid Program: MACPAC Evidence and Recommendations

February 6, 2024

While Medicaid drug spending is growing, it is increasingly driven by high-cost specialty drugs. In fiscal year (FY) 2021, Medicaid spent approximately $80.6 billion on outpatient prescription drugs and collected $42.5 billion in rebates, bringing net drug spending to $38.1 billion. In FY 2021, drugs over $1,000 per claim accounted for less than 2 percent […]